Get the Stockscreener App
0.38
17.10%
-0.0627
After Hours:
1.06
0.68
+178.95%
Biotricity Inc stock is traded at $0.38, with a volume of 80,171.
It is down -17.10% in the last 24 hours and down -36.44% over the past month.
See More
Previous Close:
$0.4427
Open:
$0.3541
24h Volume:
80,171
Relative Volume:
489.71
Market Cap:
$N/A
Revenue:
$11.63M
Net Income/Loss:
$-14.58M
P/E Ratio:
-0.217
EPS:
-1.751
Net Cash Flow:
$-7.41M
1W Performance:
-17.10%
1M Performance:
-36.44%
6M Performance:
-42.72%
1Y Performance:
-79.83%
1-Day Range:
$0.3541
$0.4199
1-Week Range:
$0.3541
$0.4199
52-Week Range:
$0.3541
$0.4199
Biotricity Inc Stock (BTCY) Company Profile
Compare BTCY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| 0.93 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
0.3112 | 544.73M | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.43 | 372.90M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.145 | 316.76M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
SHMD
Schmid Group N V
|
2.73 | 118.42M | 0 | 0 | 0 | 0.00 |
|
DAVEW
Dave Inc
|
1.10 | 0 | 0 | 0 | 0 | 0.00 |
Biotricity Inc Stock (BTCY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-07-22 | Initiated | Lake Street | Buy |
| Nov-23-21 | Initiated | H.C. Wainwright | Buy |
Biotricity Inc Stock (BTCY) Latest News
Biotricity (BTCY) Expected to Announce Earnings on Wednesday - Defense World
Analyzing Biotricity (NASDAQ:BTCY) and Stryker (NYSE:SYK) - Defense World
Biotricity (NASDAQ:BTCY) Shares Down 10.5% – Here’s Why - Defense World
Biotricity (OTCMKTS:BTCY) Stock Price Down 5.2% – Here’s What Happened - Defense World
Biotricity Receives FDA 510(k) Clearance for its Biotres Cardiac Monitoring Device - ACCESS Newswire
Press Release Distribution & PR Platform - ACCESS Newswire
Comparing Biotricity (NASDAQ:BTCY) and IceCure Medical (NASDAQ:ICCM) - Defense World
VOO ETF News, 4/8/2025 - The Globe and Mail
Biotricity Recognized by Financial Times as One of 2025’s - GlobeNewswire
Healthcare Tech Leader Biotricity's Massive 256% Growth Lands Coveted FT Recognition - Stock Titan
Biotricity to Discuss its 2022 Strategic Outlook and Product Pipeline, at Benzinga Healthcare Small Cap Conference on Sept. 30 - ACCESS Newswire
Biotricity to Present at LD Micro Invitational Investor Conference on June 7, 2016 - ACCESS Newswire
Biotricity (NASDAQ:BTCY) & Accuray (NASDAQ:ARAY) Financial Review - The AM Reporter
Holter Monitoring Systems Market Future Business - openPR.com
Biotricity Expands IP Portfolio With More Than a Dozen New Patents - Medical Product Outsourcing
Biotricity (OTC: BTCY) Expands IP Portfolio with 14 New Patents - drpjournal.com
Biotricity Announces Patient Filing for Cutting-Edge Biotres Device - ACCESS Newswire
Shares Of This Micro Cap Rally On IP Expansion News - The Globe and Mail
Biotricity expands IP portfolio with 14 new patents - TipRanks
Biotricity Expands IP Portfolio & Strategy with 14 New - GlobeNewswire
14 New Patents Power Biotricity's Game-Changing Watch-to-Patch Medical Monitor - StockTitan
Head to Head Contrast: DexCom (NASDAQ:DXCM) vs. Biotricity (NASDAQ:BTCY) - Defense World
Holter Monitoring Systems Market Growth in Future Scope - openPR
Reviewing Alphatec (NASDAQ:ATEC) and Biotricity (NASDAQ:BTCY) - Defense World
Biotricity Completes Nasdaq Listing - ACCESS Newswire
Biotricity Signs with Top 5 Group Purchasing Organization; Potential for Higher Sales Volume in 2023 - ACCESS Newswire
Biotricity to Discuss Expansion of Remote Monitoring Medical Device Products at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on September 22nd - ACCESS Newswire
Biotricity Inc (BTCY) Q3 2025 Earnings Call Highlights: Revenue Growth and Strategic Expansion Amidst Challenges - GuruFocus.com
Biotricity, Inc. to Present at Maxim Group's 2021 Inaugural Emerging Growth Virtual Conference - ACCESS Newswire
Biotricity Prices $15 Million Underwritten Public Offering of Common Stock and Listing on the Nasdaq Capital Market - ACCESS Newswire
Biotricity Announces Closing of Exercise of Underwriter's Option to Purchase Additional Common Stock - ACCESS Newswire
Medical Biometric Firm Biotricity Reshaping Market Through Pioneering Innovation - ACCESS Newswire
Biotricity Wins NIH Grant from the National Heart, Blood, and Lung Institute for AI-Enabled Real-Time Monitoring and Predictive Analytics for Stroke due to Chronic Kidney Failure - ACCESS Newswire
Biotricity to Present its Disruptive Medical Technologies at the Benzinga Global Small Cap Conference on May 14 - ACCESS Newswire
Biotricity Delivers Record Margins and Double Digit Year-Over-Year Sales Growth for Second Quarter of Fiscal Year 2024 - ACCESS Newswire
Biotricity Reports Record Quarterly and Annual Revenue for Fiscal 2021 - ACCESS Newswire
Biotricity to Discuss Sales Expansion, Recent Financing, and Wearable Medical Device Portfolio Expansion at H.C. Wainwright Conference - ACCESS Newswire
Biotricity Surpasses 2 billion Recorded and Analyzed Heartbeats for Atrial Fibrillation (AFib) - ACCESS Newswire
Patient Monitoring Devices Market Detailed In New Research - openPR
Biotricity Inc (BTCY) Q3 2025 Earnings Call Highlights: Revenue Growth and Strategic Expansion ... - Yahoo Finance
Biotricity Signs Distribution Agreement to Expand Access for its Cardiac Monitoring Solutions - ACCESS Newswire
Biotricity Launches Cardiac Monitoring Pilot Program with Major Hospital Network - ACCESS Newswire
Biotricity Announces 2021 Uplisting Strategy to Major Exchange - ACCESS Newswire
Biotricity Delivers Record Margins, Record Revenues, and - GlobeNewswire
Remote Cardiac Tech Leader Hits Triple Milestone: How Biotricity Transformed Its Financial Health - StockTitan
Biotricity Reports Revenue Growth Amidst Financial Challenges - TipRanks
Biotricity Inc reports results for the quarter ended December 31Earnings Summary - TradingView
BIOTRICITY INC. SEC 10-Q Report - TradingView
Biotricity expects to post Q3 revenue growth of 22%, cashflow breakeven - MSN
Biotricity Announces Cashflow Breakeven with Biggest Quarter in History and a Revenue Increase of 11% - GlobeNewswire
Biotricity (BTCY) Expected to Announce Earnings on Tuesday - Defense World
Biotricity Inc Stock (BTCY) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.50%
0.08%
Cap:
|
Volume (24h):